Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 44 Pancreatic Neoplasms 37 Carcinoma, Non-Small-Cell Lung 37 Triple Negative Breast Neoplasms 28 Ovarian Neoplasms 20 Fallopian Tube Neoplasms 19 Lung Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 13 Neoplasm Metastasis 11 Uterine Cervical Neoplasms 8 Melanoma 7 Inflammatory Breast Neoplasms 7 Breast Neoplasms, Male 6 Stomach Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Cholangiocarcinoma 5 Brenner Tumor 5 Pancreatic Adenocarcinoma 4 Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Transitional Cell 4 Adenocarcinoma, Bronchiolo-Alveolar 4 Adenocarcinoma of Lung 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Pleural Effusion, Malignant 3 Oropharyngeal Neoplasms 3 Nasopharyngeal Carcinoma 3 Mouth Neoplasms 3 Endometrial Neoplasms 3

Interventions

Fluorouracil 13 Cisplatin 7 Radiotherapy 6 Specimen Handling 5 Mitomycin 5 Capecitabine 5 pembrolizumab 4 dehydroftorafur 4 Radiation 4 Drug Therapy 4 Cetuximab 4 Radiotherapy, Intensity-Modulated 3 Paclitaxel 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Carboplatin 3 Biopsy 3 tislelizumab 2 durvalumab 2 aldesleukin 2 VGX-3100 2 Platinum 2 Mitozytrex 2 Immune Checkpoint Inhibitors 2 Fluorodeoxyglucose F18 2 1,2-diaminocyclohexaneplatinum II citrate 2 toripalimab 1 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 spartalizumab 1 rocakinogene sifuplasmid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anus Neoplasms × Taxes × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡